M. Herrmann, C. Farrell, I. Pusceddu, N. Fabregat-cabello, and E. Cavalier, Assessment of vitamin D status -a changing landscape, Clin Chem Lab Med. janv, vol.55, issue.1, pp.3-26, 2017.

J. Landrier, Vitamine D : sources, métabolisme et mécanismes d'action, OCL. mai, vol.21, issue.3, p.302, 2014.

O. Sizar and A. Givler, Vitamin D deficiency, StatPearls. Treasure Island (FL), 2018.

M. F. Holick, Vitamin D deficiency, N Engl J Med. juill, vol.357, issue.3, pp.266-81, 2007.

E. Tissandié, Y. Guéguen, J. Lobaccaro, J. Aigueperse, and M. Souidi,

, Med Sci MS. déc, vol.22, issue.12, pp.1095-100, 2006.

P. A. Aronov, L. M. Hall, K. Dettmer, C. B. Stephensen, and B. D. Hammock, Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry, Anal Bioanal Chem. juill, vol.391, issue.5, pp.1917-1947, 2008.

I. Schuster, Cytochromes P450 are essential players in the vitamin D signaling system, Biochim Biophys Acta. janv, vol.1814, issue.1, pp.186-99, 2011.

C. R. Bosworth, G. Levin, C. Robinson-cohen, A. N. Hoofnagle, J. Ruzinski et al., The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease, Kidney Int. sept, vol.82, issue.6, pp.693-700, 2012.

K. P. Schlingmann, M. Kaufmann, S. Weber, A. Irwin, C. Goos et al., Mutations in CYP24A1 and idiopathic infantile hypercalcemia, N Engl J Med. août, vol.365, issue.5, pp.410-431, 2011.

J. Tang, H. Nicholls, I. Piec, C. J. Washbourne, J. J. Dutton et al., Reference intervals for serum 24,25-dihydroxyvitamin D and the ratio with 25-hydroxyvitamin D established using a newly developed LC-MS/MS method, J Nutr Biochem. août, vol.46, pp.21-30, 2017.

D. E. Prosser, M. Kaufmann, B. O'leary, V. Byford, and G. Jones, Single A326G mutation converts human CYP24A1 from 25-OH-D?-24-hydroxylase into -23-hydroxylase, generating 1alpha,25-(OH)2D?-26,23-lactone, Proc Natl Acad Sci, vol.104, issue.31, pp.12673-12681, 2007.

M. Hewison, An update on vitamin D and human immunity, Clin Endocrinol (Oxf). mars, vol.76, issue.3, pp.315-340, 2012.

Z. Wang, Y. Wang, B. Xu, J. Liu, Y. Ren et al., Vitamin D improves immune function in immunosuppressant mice induced by glucocorticoid, Biomed Rep. janv, vol.6, issue.1, pp.120-124, 2017.

E. Ko?ovská, F. Gaughran, A. Krivoy, and U. Meier, Vitamin-D deficiency as a potential environmental risk factor in multiple sclerosis, schizophrenia, and autism. Front Psychiatry, vol.8, p.47, 2017.

S. Rafiq and P. B. Jeppesen, Is hypovitaminosis D related to incidence of type 2 diabetes and high fasting glucose level in healthy subjects : a systematic review and meta-analysis of observational studies, Nutrients. janv, vol.10, issue.1, 2018.

M. J. Alkhatatbeh and K. K. Abdul-razzak, Association between serum 25-hydroxyvitamin D, hemoglobin A1c and fasting blood glucose levels in adults with diabetes mellitus, Biomed Rep. déc, vol.9, issue.6, pp.523-553, 2018.

P. D. Chandler, D. K. Tobias, L. Wang, S. A. Smith-warner, D. I. Chasman et al., Association between Vitamin D Genetic Risk Score and Cancer Risk in a Large Cohort, Nutrients. janv, vol.10, issue.1, 2018.

Z. Heidari, M. Nikbakht, M. A. Mashhadi, M. Jahantigh, N. Mansournia et al., Vitamin D deficiency associated with differentiated thyroid carcinoma : a case-control study, Asian Pac J Cancer Prev APJCP. déc, vol.18, issue.12, pp.3419-3441, 2017.

E. L. Heyden and S. J. Wimalawansa, Vitamin D: Effects on human reproduction, pregnancy, and fetal well-being, J Steroid Biochem Mol Biol. juin, vol.180, pp.41-50, 2018.

P. Koduah, F. Paul, and J. Dörr, Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases, EPMA J. déc, vol.8, issue.4, pp.313-338, 2017.

A. Zittermann, The biphasic effect of vitamin D on the musculoskeletal and cardiovascular system, Int J Endocrinol. août, p.3206240, 2017.

K. A. Kennel, M. T. Drake, and D. L. Hurley, Vitamin D deficiency in adults: when to test and how to treat, Mayo Clin Proc. août, vol.85, issue.8, pp.757-765, 2010.

H. A. Bischoff-ferrari, E. Giovannucci, W. C. Willett, T. Dietrich, and B. Dawson-hughes, Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes, Am J Clin Nutr. juill, vol.84, issue.1, pp.18-28, 2006.

R. Bouillon, Comparative analysis of nutritional guidelines for vitamin D, Nat Rev Endocrinol. août, vol.13, issue.8, pp.466-79, 2017.

H. Autorité-de-santé, Vitamine D-Note de cadrage, vol.42, 2013.

M. L. Melamed, E. D. Michos, W. Post, and B. Astor, 25-hydroxyvitamin D levels and the risk of mortality in the general population, Arch Intern Med. août, vol.168, issue.15, pp.1629-1666, 2008.

M. K. Thomas, D. M. Lloyd-jones, R. I. Thadhani, A. C. Shaw, D. J. Deraska et al., Hypovitaminosis D in medical inpatients, N Engl J Med. mars, vol.338, issue.12, pp.777-83, 1998.

P. Autier and S. Gandini, Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials, Arch Intern Med. sept, vol.167, issue.16, pp.1730-1737, 2007.

M. Mazidi, E. Karimi, P. Rezaie, and H. Vatanparast, The impact of vitamin D supplement intake on vascular endothelial function; a systematic review and meta-analysis of randomized controlled trials, Food Nutr Res. janv, vol.61, issue.1, p.1273574, 2017.

N. Griffin and M. Dowling, Vitamin D supplementation and clinical outcomes in cancer survivorship, Br J Nurs Mark Allen Publ. oct, vol.27, pp.1121-1129, 2018.

J. E. Manson, N. R. Cook, I. Lee, C. W. Bassuk, S. S. Mora et al., Vitamin D supplements and prevention of cancer and cardiovascular disease, N Engl J Med. janv, vol.380, issue.1, pp.33-44, 2019.

C. T. Sempos, R. A. Durazo-arvizu, B. Dawson-hughes, E. A. Yetley, A. C. Looker et al., Is there a reverse J-shaped association between 25-hydroxyvitamin D and all-cause mortality? Results from the U.S. nationally representative NHANES, J Clin Endocrinol Metab. juill, vol.98, issue.7, pp.3001-3010, 2013.

D. Durup, H. L. Jørgensen, J. Christensen, P. Schwarz, A. M. Heegaard et al., A reverse Jshaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study, J Clin Endocrinol Metab. août, vol.97, issue.8, pp.2644-52, 2012.

R. Lightwood, Idiopathic hypercalcaemia with failure to thrive: nephrocalcinosis, Proc R Soc Med, vol.45, p.401, 1952.

R. Lightwood and T. Stapleton, Idiopathic hypercalcaemia in infants, Lancet Lond Engl. août, vol.265, issue.6779, pp.255-261, 1953.

R. Lightwood, Hypercalcaemia in Infants and Vitamin D, Br Med J. juill, vol.2, issue.4985, p.149, 1956.

D. W. Smith, R. M. Blizzard, and H. E. Harrison, Idiopathic hypercalcemia ; a case report with assays of vitamin D in the serum, Pediatrics. août, vol.24, issue.2, pp.258-69, 1959.

F. M. Kenny, T. Aceto, M. Purisch, H. E. Harrison, H. C. Harrison et al., Metabolic studies in a patient with idiopathic hypercalcemia of infancy, J Pediatr. avr, vol.62, pp.531-538, 1963.

K. Méhes, Z. Szelid, and P. Tóth, Possible dominant inheritance of the idiopathic hypercalcemic syndrome, Hum Hered, vol.25, issue.1, pp.30-34, 1975.

M. Nguyen, H. Boutignon, E. Mallet, A. Linglart, H. Guillozo et al., Infantile hypercalcemia and hypercalciuria: new insights into a vitamin D-dependent mechanism and response to ketoconazole treatment, J Pediatr. août, vol.157, issue.2, pp.296-302, 2010.

M. Kaufmann, J. C. Gallagher, M. Peacock, K. Schlingmann, K. M. Deluca et al., Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD, J Clin Endocrinol Metab. juill, vol.99, issue.7, pp.2567-74, 2014.

H. Ketha, R. Kumar, and R. J. Singh, LC-MS/MS for Identifying Patients with CYP24A1 Mutations, Clin Chem. janv, vol.62, issue.1, pp.236-278, 2016.

T. Yoshida, T. Fujimori, and Y. Nabeshima, Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1?-hydroxylase gene, Endocrinology. févr, vol.143, issue.2, pp.683-692, 2002.

E. A. Streeten, K. Zarbalian, and C. M. Damcott, CYP24A1 mutations in idiopathic infantile hypercalcemia, N Engl J Med. nov, vol.365, issue.18, pp.1742-1743, 2011.

A. Dauber, T. T. Nguyen, E. Sochett, D. Cole, R. Horst et al., Genetic defect in CYP24A1, the vitamin D 24-hydroxylase gene, in a patient with severe infantile hypercalcemia, J Clin Endocrinol Metab. févr, vol.97, issue.2, pp.268-274, 2012.

P. J. Tebben, D. S. Milliner, R. L. Horst, P. C. Harris, R. J. Singh et al., Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy, J Clin Endocrinol Metab. mars, vol.97, issue.3, pp.423-427, 2012.

E. Meusburger, A. Mündlein, E. Zitt, B. Obermayer-pietsch, D. Kotzot et al., Medullary nephrocalcinosis in an adult patient with idiopathic infantile hypercalcaemia and a novel CYP24A1 mutation, Clin Kidney J. avr, vol.6, issue.2, pp.211-216, 2013.

F. Fencl, K. Bláhová, K. P. Schlingmann, M. Konrad, and T. Seeman, Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene, Eur J Pediatr. janv, vol.172, issue.1, pp.45-54, 2013.

G. Colussi, L. Ganon, S. Penco, D. Ferrari, M. E. Ravera et al., Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc. mars, vol.29, issue.3, pp.636-679, 2014.

P. Wolf, T. Müller-sacherer, S. Baumgartner-parzer, Y. Winhofer, J. Kroo et al., A case of « late-onset » Idiopathic Infantile Hypercalcemia secondary to mutations in the CYP24A1 gene, Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol. mai, vol.20, issue.5, pp.91-95, 2014.

G. Nesterova, M. C. Malicdan, K. Yasuda, T. Sakaki, T. Vilboux et al., OH)2D-24 hydroxylase (CYP24A1) deficiency as a cause of nephrolithiasis, Clin J Am Soc Nephrol CJASN. avr, vol.8, issue.4, pp.649-57, 2013.

D. Dinour, P. Beckerman, L. Ganon, K. Tordjman, Z. Eisenstein et al., Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis, J Urol. août, vol.190, issue.2, pp.552-559, 2013.

M. Castanet, E. Mallet, and M. Kottler, Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations, J Pediatr, vol.163, issue.4, pp.1208-1218, 2013.

A. Molin, R. Baudoin, M. Kaufmann, J. C. Souberbielle, A. Ryckewaert et al., CYP24A1 mutations in a cohort of hypercalcemic patients : evidence for a recessive trait, J Clin Endocrinol Metab, vol.100, issue.10, pp.1343-1352, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02423834

. Cyp24a1-|-gnomad,

M. Cools, S. Goemaere, D. Baetens, A. Raes, A. Desloovere et al., Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study, Bone. déc, vol.81, pp.89-96, 2015.

D. Dinour, M. Davidovits, S. Aviner, L. Ganon, L. Michael et al., Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake, Pediatr Nephrol Berl Ger. janv, vol.30, issue.1, pp.145-52, 2015.

G. D. Carter, 25-hydroxyvitamin D: a difficult analyte, Clin Chem. mars, vol.58, issue.3, pp.486-494, 2012.

S. Ding, I. Schoenmakers, K. Jones, A. Koulman, A. Prentice et al., Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS, Anal Bioanal Chem. sept, vol.398, issue.2, pp.779-89, 2010.

A. C. Heijboer, M. A. Blankenstein, I. P. Kema, and M. M. Buijs, Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration, Clin Chem. mars, vol.58, issue.3, pp.543-551, 2012.

Z. Wang, T. Senn, T. Kalhorn, X. E. Zheng, S. Zheng et al., Simultaneous measurement of plasma vitamin D? metabolites, including 4?,25-dihydroxyvitamin D?, using liquid chromatography-tandem mass spectrometry, Anal Biochem, vol.418, issue.1, pp.126-159, 2011.

. La_quantification_en_spectrometrie_de_masse_triple_quadripoles and . Pdf,

D. Sur,

, Principe de la source ionisation électrospray

. Spectrométrie-de-masse, , 2016.

P. Marquet, Théorie et instrumentation des techniques de LC-MS et LC-MS/MS applicables à la toxicologie, Ann Toxicol Anal. mars, vol.17, issue.1, pp.5-12, 2005.

. Chm3102_ms2 and . Pdf,

N. Fabregat-cabello, J. Farre-segura, L. Huyghebaert, S. Peeters, L. Goff et al., A fast and simple method for simultaneous measurements of 25(OH)D, 24,25(OH)2D and the Vitamin D Metabolite Ratio (VMR) in serum samples by LC-MS/MS, Clin Chim Acta Int J Clin Chem, vol.473, pp.116-139, 2017.

X. Duan, B. Weinstock-guttman, H. Wang, E. Bang, J. Li et al., Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry, Anal Chem. mars, vol.82, issue.6, pp.2488-97, 2010.

A. Mena-bravo, C. Ferreiro-vera, F. Priego-capote, M. A. Maestro, A. Mouriño et al., Quantitative analytical method to evaluate the metabolism of vitamin D, Clin Chim Acta Int J Clin Chem. mars, vol.442, pp.6-12, 2015.

F. Priego-capote, J. R. Jiménez, J. Granados, and M. De-castro, Identification and determination of fat-soluble vitamins and metabolites in human serum by liquid chromatography/triple quadrupole mass spectrometry with multiple reaction monitoring, Rapid Commun Mass Spectrom RCM. mars, vol.21, issue.11, pp.1745-54, 2007.

R. D. Coldwell, D. J. Trafford, M. J. Varley, D. N. Kirk, and H. L. Makin, Stable isotope-labeled vitamin D, metabolites and chemical analogs: synthesis and use in mass spectrometric studies, Steroids. oct, vol.55, issue.10, pp.418-450, 1990.

D. Portal,

D. Wagner, H. E. Hanwell, K. Schnabl, M. Yazdanpanah, S. Kimball et al., The ratio of serum 24,25-dihydroxyvitamin D? to 25-hydroxyvitamin D? is predictive of 25-hydroxyvitamin D? response to vitamin D? supplementation, J Steroid Biochem Mol Biol. sept, vol.126, issue.3-5, pp.72-79, 2011.

A. Burild, H. L. Frandsen, and J. Jakobsen, Simultaneous quantification of vitamin D?, 25-hydroxyvitamin D? and 24,25-dihydroxyvitamin D? in human serum by LC-MS/MS, Scand J Clin Lab Invest. août, vol.74, issue.5, pp.418-441, 2014.

. Chemhelper, Diels-Alder Mechanism

. Amplifex_diene_125dhvd3,

F. G. Strathmann, T. J. Laha, and A. N. Hoofnagle, Quantification of 1?,25-dihydroxy vitamin D by immunoextraction and liquid chromatography-tandem mass spectrometry, Clin Chem. sept, vol.57, issue.9, pp.1279-85, 2011.

T. E. Lipkie, A. Janasch, B. R. Cooper, E. E. Hohman, C. M. Weaver et al., Quantification of vitamin D and 25-hydroxyvitamin D in soft tissues by liquid chromatography-tandem mass spectrometry, J Chromatogr B Analyt Technol Biomed Life Sci. août, vol.932, pp.6-11, 2013.

T. Khayamian and M. T. Jafari, Design for electrospray ionization-ion mobility spectrometry, Anal Chem. avr, vol.79, issue.8, pp.3199-205, 2007.

D. Lee and G. Chang, Quantitative liquid chromatography-electrospray ionization-mass spectrometry analysis of amine-containing metabolites derivatized with cyanuric chloride and methylamine isotopologues, J Chromatogr A. avr, vol.1388, pp.60-68, 2015.

H. Zhao, Improvement of detection sensitivity of triglyceride with methylamine formate as ionization enhancer in reversed phase liquid chromatography-electrospray ionization mass spectrometry, Chin J Anal Chem. sept, vol.45, issue.9, pp.1323-1332, 2017.

T. Higashi, Y. Shibayama, M. Fuji, and K. Shimada, Liquid chromatography-tandem mass spectrometric method for the determination of salivary 25-hydroxyvitamin D? : a noninvasive tool for the assessment of vitamin D status, Anal Bioanal Chem. mai, vol.391, issue.1, pp.229-267, 2008.

J. P?otka-wasylka, M. Mar?, N. Szczepa?ska, and J. Namie?nik, New polymeric materials for solid phase extraction, Crit Rev Anal Chem. sept, vol.47, issue.5, pp.373-83, 2017.

L. Silvestro and S. R. Savu, An update on solid phase-supported liquid extraction, Bioanalysis, vol.7, issue.17, pp.2177-86, 2015.

. Biotage, Ultra-sensitive method for determining vitamin D2 and D? metabolites in serum, 2015.

D. Sur,

N. Tsugawa, Y. Suhara, M. Kamao, and T. Okano, Determination of 25-hydroxyvitamin D in human plasma using high-performance liquid chromatography--tandem mass spectrometry, Anal Chem. mai, vol.77, issue.9, pp.3001-3008, 2005.

J. Adamec, A. Jannasch, J. Huang, E. Hohman, J. C. Fleet et al., Development and optimization of an LC-MS/MS-based method for simultaneous quantification of vitamin D2, vitamin D? , 25-hydroxyvitamin D2 and 25-hydroxyvitamin D?, J Sep Sci. janv, vol.34, issue.1, pp.11-20, 2011.

E. Pronicka, C. E. Halat, P. Janiec, A. Wójcik, M. Rowi?ska et al., Biallelic mutations in CYP24A1 or SLC34A1 as a cause of infantile idiopathic hypercalcemia (IIH) with vitamin D hypersensitivity : molecular study of 11 historical IIH cases, J Appl Genet. août, vol.58, issue.3, pp.349-53, 2017.